Skip to content
Review

Single Cell Proteomics to Spatial Multiomics in Cardiovascular Disease: Foundations, Technologies, and Biological Insights.

Jul 2026 · Circulation Research · Vol 139 4, pp. e327684 · 0 citations · 177 references
Medicine

TL;DR

This compendium review works to stimulate new research into spatial regulation of the heart, emphasizing integration of single-cell proteomic regulation with comprehensive multiomic mass spectrometry imaging studies.

Abstract

It is now apparent that cardiac form and function are governed at a system level by an integrated collective of heterogeneous single-cell programs that together regulate tissue homeostasis, drive disease emergence, and shape individualized responses to therapy. Current advances in single-cell proteomics and spatial multiomics by mass spectrometry imaging allow systematic dissection of clinically defined cardiovascular tissues with an unprecedented molecular resolving power, yet remain relatively underutilized in cardiovascular research. This compendium review works to stimulate new research into spatial regulation of the heart, emphasizing integration of single-cell proteomic regulation with comprehensive multiomic mass spectrometry imaging studies. In this context, we outline conceptual foundations, technological innovations, and biological insights that have resulted in the current success of single-cell proteomic and spatial multiomic analyses in cardiovascular disease. We provide an experimental design knowledge base of critical components in single-cell proteomics and spatial workflows by mass spectrometry imaging, essential for generating robust and reproducible data sets that are interpretable by advanced computational methods. Key cardiovascular discoveries by single-cell proteomics and multiomic mass spectrometry imaging are reviewed, highlighting how these approaches have provided new molecular insights into cardiac cell programming.

View source

Similar papers

Review Open access Sep 2026

Spatial multiomics in biomedical research: advances beyond transcriptomics

Coordinated changes in gene expression, epigenetic regulation, protein and metabolic activities together drive disease progression and determine clinical outcomes. While spatially resolved transcriptomics has been widely adopted across biomedical fields, it offers an incomplete picture limited to transcriptomic levels....

Xin-Chen Mao, Zhuo Chen, Emily J. Hwang et al. · 0 citations
Review Aug 2026

Advances in Single-Cell Metabolomics and Their Applications in Disease Biology

Single-cell metabolomics (SCM) provides a functional view of cellular heterogeneity by measuring metabolic states at cellular or subcellular resolution. Unlike bulk metabolomics, SCM can reveal rare metabolic cell states, spatially restricted metabolic niches, dynamic pathway activity, and treatment-associated metaboli...

Jie Du, Hui-Hui Tao, Yu-Jie Zhang et al. · 0 citations
Review Aug 2026

EXPRESS: Harnessing Single-Cell Gene Regulatory Networks for Precision Health.

This manuscript explores the current landscape of single-cell RNA sequencing (scRNA-seq), highlighting key studies that have leveraged this technology to advance biological understanding for clinical purposes through the construction of gene regulatory networks (GRNs) from single-cell transcriptomic data.

J. López-Castiblanco, L. López-Kleine, Yesid Cuesta-Astroz · 0 citations
Review Sep 2026

Annotation of Cell Types in Single-Cell Sequencing for Cardiovascular Disease: Concepts, Workflows, Challenges, and Best Practices.

This Review systematically integrates current conceptual frameworks, computational methodologies, and domain-specific best practices for cell-type annotation in cardiovascular single-cell research and offers practical recommendations and discuss future directions encompassing multimodal integration, spatial transcripto...

Lu Sun, Li Ma, Li-Zhi Chen et al. · 0 citations
Review Open access Aug 2026

From Single Cells to Diagnosis: Proteomics Technologies in the Multi‐Omics Landscape of Rare and Mitochondrial Diseases

Proteomics by mass spectrometry has rapidly matured from a niche method into a standard tool. The recent 10‐year trajectory of single‐cell proteomics has opened a new biological dimension for studying disease. Mitochondrial diseases, with their pronounced cell‐to‐cell heterogeneity, are particularly, well‐suited to the...

Simon Wetzel, S. P. Mann, F. Rosenberger · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.